This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CSN Posts Net Revenue Of R$8.0 Billion, EBITDA Of R$2.2 Billion, EBITDA Margin Of 28% And Net Income Of R$644 Million Without The Reclassification Of Available-For-Sale Investment In The 1H12

SAO PAULO, Aug. 14, 2012 /PRNewswire/ -- CSN - Companhia Siderurgica Nacional (BM&FBOVESPA: CSNA3) (NYSE: SID) announces its results for the 2Q12:
  • Net revenue reached R$4.1 billion in 2Q12;
  • 2Q12 gross profit amounted to R$1.2 billion;
  • Adjusted EBITDA in 2Q12 totaled R$1.1 billion;
  • Adjusted EBITDA margin in 2Q12 reached 27%;
  • In 2Q12, the Company posted net loss of R$1 billion due to the accounting reclassification of available-for-sale investment, with no cash impact. Excluding the effects of this reclassification, the Company would have posted a net income of R$551 million in 2Q12.

The full Earnings Release is available on CSN's IR website at www.csn.com.br/ir.

CSN will be hosting conference calls about its 2Q12 Earnings on WEDNESDAY, August 15, 2012, at 11:00 a.m. US ET in English and 9:00 a.m. US ET in Portuguese. Connection details may be obtained on the Company's IR website.

Investor Relations David Salama Investor Relations Executive Officer Phone: +55 11 3049-7588 david.salama@csn.com.br

SOURCE CSN - Companhia Siderugica Nacional
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs